ロード中...
Clinical Evaluation of BRCA1/2 Mutation in Mexican Ovarian Cancer Patients
Ovarian cancer (OC) is an important cause of gynecologic cancer-related deaths. In Mexico, around 4700 new cases of OC are diagnosed per year and it represents the second cause of gynecological cancer mortality with more than 2700 deaths. Germline mutations in BRCA1/2 genes are present in 13–18% of...
保存先:
| 出版年: | Transl Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Neoplasia Press
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6931216/ https://ncbi.nlm.nih.gov/pubmed/31869745 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2019.11.003 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|